CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways

Kiyoko Nakamura(Osaka Medical and Pharmaceutical University), Masahide Ohmichi(Osaka Medical and Pharmaceutical University)
Oncology Reports
April 19, 2017
Cited by 115


Related Papers